Literature DB >> 15472838

Diagnosis and treatment of diabetic foot infections.

Benjamin A Lipsky1, Anthony R Berendt, H Gunner Deery, John M Embil, Warren S Joseph, Adolf W Karchmer, Jack L LeFrock, Daniel P Lew, Jon T Mader, Carl Norden, James S Tan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15472838     DOI： 10.1086/424846

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  162 in total

1.  Tissue penetration and pharmacokinetics of tigecycline in diabetic patients with chronic wound infections described by using in vivo microdialysis.

Authors:  Catharine C Bulik; Dora E Wiskirchen; Ashley Shepard; Christina A Sutherland; Joseph L Kuti; David P Nicolau
Journal:  Antimicrob Agents Chemother       Date:  2010-10-04       Impact factor: 5.191

2.  The major predictors of amputation and length of stay in diabetic patients with acute foot ulceration.

Authors:  Suzan Tabur; Mehmet Ali Eren; Yakup Çelik; Omer Faruk Dağ; Tevfik Sabuncu; Zeynel Abidin Sayiner; Esen Savas
Journal:  Wien Klin Wochenschr       Date:  2014-11-15       Impact factor: 1.704

3.  Association of complement C3 and interleukin-1 with foot infections in diabetic patients.

Authors:  Z M H Kheiralla; S S Maklad; S M Ashour; E El-Sayed Moustafa
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2012-09-10

4.  Comparative in vitro susceptibilities of 396 unusual anaerobic strains to tigecycline and eight other antimicrobial agents.

Authors:  Ellie J C Goldstein; Diane M Citron; C Vreni Merriam; Yumi A Warren; Kerin L Tyrrell; Helen T Fernandez
Journal:  Antimicrob Agents Chemother       Date:  2006-08-28       Impact factor: 5.191

Review 5.  Surgical revascularization techniques for diabetic foot.

Authors:  Siva Krishna Kota; Sunil Kumar Kota; Lalit Kumar Meher; Satyajit Sahoo; Sudeep Mohapatra; Kirtikumar Dharmsibhai Modi
Journal:  J Cardiovasc Dis Res       Date:  2013-06-18

6.  Interaction of dihydrofolate reductase and aminoglycoside adenyltransferase enzyme from Klebsiella pneumoniae multidrug resistant strain DF12SA with clindamycin: a molecular modelling and docking study.

Authors:  Shailesh K Shahi; Vinay K Singh; Ashok Kumar; Sanjeev K Gupta; Surya K Singh
Journal:  J Mol Model       Date:  2012-10-25       Impact factor: 1.810

7.  Role of magnetic resonance imaging in the evaluation of diabetic foot with suspected osteomyelitis.

Authors:  U Rozzanigo; A Tagliani; E Vittorini; R Pacchioni; L Renzi Brivio; R Caudana
Journal:  Radiol Med       Date:  2008-10-25       Impact factor: 3.469

8.  Ceftaroline plus avibactam demonstrates bactericidal activity against pathogenic anaerobic bacteria in a one-compartment in vitro pharmacokinetic/pharmacodynamic model.

Authors:  Brian J Werth; Michael J Rybak
Journal:  Antimicrob Agents Chemother       Date:  2013-11-11       Impact factor: 5.191

9.  Intralesional administration of epidermal growth factor-based formulation (Heberprot-P) in chronic diabetic foot ulcer: treatment up to complete wound closure.

Authors:  José I Fernández-Montequín; Blas Y Betancourt; Gisselle Leyva-Gonzalez; Ernesto L Mola; Katia Galán-Naranjo; Mayte Ramírez-Navas; Sergio Bermúdez-Rojas; Felix Rosales; Elizeth García-Iglesias; Jorge Berlanga-Acosta; Ricardo Silva-Rodriguez; Marianela Garcia-Siverio; Luis H Martinez
Journal:  Int Wound J       Date:  2009-02       Impact factor: 3.315

10.  Clinical signs of infection in diabetic foot ulcers with high microbial load.

Authors:  Sue E Gardner; Stephen L Hillis; Rita A Frantz
Journal:  Biol Res Nurs       Date:  2009-10       Impact factor: 2.522
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.